CCA
CLB icon

Conestoga Capital Advisors’s Core Laboratories CLB Stock Holding History

Conestoga Capital Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-36,016
Closed -$1.36M – 143
2019
Q4 		$1.36M Buy
36,016
+856
+2% +$38.5K 0.03% 74
2019
Q3 		$1.64M Buy
35,160
+17,110
+95% +$795K 0.04% 72
2019
Q2 		$944K Buy
18,050
+250
+1% +$14.7K 0.02% 76
2019
Q1 		$1.23M Buy
17,800
+2,118
+14% +$142K 0.03% 76
2018
Q4 		$936K Sell
15,682
-500
-3% -$43.1K 0.03% 78
2018
Q3 		$1.87M Buy
16,182
+2,795
+21% +$315K 0.05% 73
2018
Q2 		$1.69M Buy
13,387
+575
+4% +$70K 0.05% 73
2018
Q1 		$1.39M Buy
12,812
+505
+4% +$55.9K 0.05% 73
2017
Q4 		$1.35M Sell
12,307
-2,450
-17% -$245K 0.05% 72
2017
Q3 		$1.46M Buy
14,757
+3,029
+26% +$294K 0.06% 71
2017
Q2 		$1.19M Sell
11,728
-50
-0.4% -$5.39K 0.06% 65
2017
Q1 		$1.36M Buy
11,778
+6,450
+121% +$750K 0.08% 60
2016
Q4 		$640K Buy
5,328
+40
+0.8% +$4.43K 0.04% 65
2016
Q3 		$594K Hold
5,288
– – 0.04% 65
2016
Q2 		$655K Sell
5,288
-100
-2% -$12.1K 0.05% 58
2016
Q1 		$606K Hold
5,388
– – 0.04% 59
2015
Q4 		$586K Sell
5,388
-27
-0.5% -$3.09K 0.05% 60
2015
Q3 		$540K Buy
5,415
+75
+1% +$8.16K 0.04% 61
2015
Q2 		$609K Buy
5,340
+27
+0.5% +$3.27K 0.04% 60
2015
Q1 		$555K Buy
5,313
+143
+3% +$15.2K 0.04% 66
2014
Q4 		$622K Buy
5,170
+2,400
+87% +$315K 0.04% 63
2014
Q3 		$405K Sell
2,770
-350
-11% -$54K 0.03% 74
2014
Q2 		$521K Sell
3,120
-9,500
-75% -$1.69M 0.04% 64
2014
Q1 		$2.5M Sell
12,620
-290
-2% -$54.7K 0.16% 52
2013
Q4 		$2.46M Buy
12,910
+8,500
+193% +$1.58M 0.17% 55
2013
Q3 		$746K Sell
4,410
-62,939
-93% -$9.77M 0.06% 55
2013
Q2 		$10.2M Buy
+67,349
New +$9.54M 1.05% 41

Other funds holding CLB

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Conestoga Capital Advisors's CLB Position: Q1 2020 in Review

Conestoga Capital Advisors sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 36,016 shares — an estimated $1.36M sold.

Conestoga Capital Advisors first reported a position in CLB in Q2 2013 and held it in 27 quarters. The position peaked at $10.2M in Q2 2013. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Conestoga Capital Advisors reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Conestoga Capital Advisors sold 36,016 Core Laboratories shares in Q1 2020, an estimated $1.36M.
  • Conestoga Capital Advisors first reported a position in Core Laboratories in Q2 2013 and held it in 27 quarters.
  • Conestoga Capital Advisors's Core Laboratories position peaked at $10.2M in Q2 2013.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Conestoga Capital Advisors's 13F filing for Q1 2020, filed 17 Apr 2020.